STOCK TITAN

Standard BioTools Inc. - $LAB STOCK NEWS

Welcome to our dedicated page for Standard BioTools news (Ticker: $LAB), a resource for investors and traders seeking the latest updates and insights on Standard BioTools stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Standard BioTools's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Standard BioTools's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.87%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.45%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.45%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.11%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10%
Tags
buyback
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.22%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.1%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.95%
Tags
Standard BioTools Inc.

Nasdaq:LAB

LAB Rankings

LAB Stock Data

973.67M
50.24M
0.69%
56.05%
2.67%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
United States of America
SOUTH SAN FRANCISCO

About LAB

fluidigm (nasdaq:fldm) develops, manufactures and markets microfluidic systems for growth markets in the life sciences and in applied markets. fluidigm’s systems consist of instruments, software, integrated fluidic circuits (ifcs), high-performance assays for gene expression and genotyping, and primers for sample preparation for next-generation sequencing. fluidigm technology enables customers to perform thousands of sophisticated biochemical measurements in parallel on samples smaller than the content of a single cell, with nanoliter volumes of reagents, in half the area of a credit card. the company’s integrated customer solutions are designed to significantly simplify experimental workflows, increase throughput and reduce costs while delivering excellent data quality. based in south san francisco, fluidigm offers an exciting and collegial working environment with excellent compensation and benefits, including equity.